APO Research
Talk to an analyst

APO RESEARCH · REPORT

Steroidal MRAs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Steroidal MRAs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchSteroidal MRAs Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Steroidal MRAs Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Steroidal MRAs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Steroidal MRAs Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Steroidal MRAs Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Steroidal MRAs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Steroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Steroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Steroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Steroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Steroidal MRAs include Chongqing Kerui Pharmaceutical, Jiangsu Chia Tai Fenghai Pharmaceutical, Grand Pharmaceutical, Yatai Pharma, Suzhou Homesun Pharmaceutical, Shanghai Xinyi Wanxiang pharmaceutical, Jiangsu Changjiang Pharmaceutical, Jiangsu Yunyang Pharmaceutical Group and Hangzhou Minsheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Steroidal MRAs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Steroidal MRAs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Steroidal MRAs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Steroidal MRAs market size, projected growth trends, production technologies, key applications, and end-use industries.

Steroidal MRAs Segment by Company

Chongqing Kerui Pharmaceutical

Jiangsu Chia Tai Fenghai Pharmaceutical

Grand Pharmaceutical

Yatai Pharma

Suzhou Homesun Pharmaceutical

Shanghai Xinyi Wanxiang pharmaceutical

Jiangsu Changjiang Pharmaceutical

Jiangsu Yunyang Pharmaceutical Group

Hangzhou Minsheng Pharmaceutical

Sinopharm Zhonglian Pharmaceutical

Zydus

Viatris Pharmaceuticals

Sun Pharmaceuticals

Sandoz

Pfizer

Mylan

MSN

Kyorin Rimedio

Camber Pharmaceuticals

Amneal Pharmaceuticals

Actavis Elizabeth

Accord Healthcare

Steroidal MRAs Segment by Type

Spironolactone

Eplerenone

Steroidal MRAs Segment by Application

Hypertension

Aldosteronism

Edema

Heart failure

Others

Steroidal MRAs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Steroidal MRAs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Steroidal MRAs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Steroidal MRAs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Steroidal MRAs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Steroidal MRAs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Steroidal MRAs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Steroidal MRAs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Steroidal MRAs Industry Trends Table 2. Steroidal MRAs Industry Drivers Table 3. Steroidal MRAs Industry Opportunities and Challenges Table 4. Steroidal MRAs Industry Restraints Table 5. Global Steroidal MRAs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Steroidal MRAs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Steroidal MRAs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Steroidal MRAs Sales Market Share by Manufacturers Table 9. Global Steroidal MRAs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Steroidal MRAs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Steroidal MRAs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Steroidal MRAs Manufacturers, Product Type & Application Table 13. Global Steroidal MRAs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Steroidal MRAs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Spironolactone Table 17. Major Manufacturers of Eplerenone Table 18. Global Steroidal MRAs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Steroidal MRAs Sales by Type (2021-2026) & (K Units) Table 20. Global Steroidal MRAs Sales by Type (2027-2032) & (K Units) Table 21. Global Steroidal MRAs Sales Market Share by Type (2021-2026) Table 22. Global Steroidal MRAs Sales Market Share by Type (2027-2032) Table 23. Global Steroidal MRAs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Steroidal MRAs Revenue by Type (2021-2026) & (K Units) Table 25. Global Steroidal MRAs Revenue by Type (2027-2032) & (K Units) Table 26. Global Steroidal MRAs Revenue Market Share by Type (2021-2026) Table 27. Global Steroidal MRAs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hypertension Table 29. Major Manufacturers of Aldosteronism Table 30. Major Manufacturers of Edema Table 31. Major Manufacturers of Heart failure Table 32. Major Manufacturers of Others Table 33. Global Steroidal MRAs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Steroidal MRAs Sales by Application (2021-2026) & (K Units) Table 35. Global Steroidal MRAs Sales by Application (2027-2032) & (K Units) Table 36. Global Steroidal MRAs Sales Market Share by Application (2021-2026) Table 37. Global Steroidal MRAs Sales Market Share by Application (2027-2032) Table 38. Global Steroidal MRAs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Steroidal MRAs Revenue by Application (2021-2026) & (K Units) Table 40. Global Steroidal MRAs Revenue by Application (2027-2032) & (K Units) Table 41. Global Steroidal MRAs Revenue Market Share by Application (2021-2026) Table 42. Global Steroidal MRAs Revenue Market Share by Application (2027-2032) Table 43. Global Steroidal MRAs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Steroidal MRAs Sales by Region (2021-2026) & (K Units) Table 45. Global Steroidal MRAs Sales Market Share by Region (2021-2026) Table 46. Global Steroidal MRAs Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Steroidal MRAs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Steroidal MRAs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Steroidal MRAs Sales by Country (2021-2026) & (K Units) Table 50. North America Steroidal MRAs Sales by Country (2027-2032) & (K Units) Table 51. Europe Steroidal MRAs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Steroidal MRAs Sales by Country (2021-2026) & (K Units) Table 53. Europe Steroidal MRAs Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Steroidal MRAs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Steroidal MRAs Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Steroidal MRAs Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Steroidal MRAs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Steroidal MRAs Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Steroidal MRAs Sales by Country (2027-2032) & (K Units) Table 60. Global Steroidal MRAs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Steroidal MRAs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Steroidal MRAs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Steroidal MRAs Revenue Market Share by Region (2021-2026) Table 64. Global Steroidal MRAs Revenue Market Share by Region (2027-2032) Table 65. Chongqing Kerui Pharmaceutical Company Information Table 66. Chongqing Kerui Pharmaceutical Business Overview Table 67. Chongqing Kerui Pharmaceutical Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Chongqing Kerui Pharmaceutical Steroidal MRAs Product Portfolio Table 69. Chongqing Kerui Pharmaceutical Recent Development Table 70. Jiangsu Chia Tai Fenghai Pharmaceutical Company Information Table 71. Jiangsu Chia Tai Fenghai Pharmaceutical Business Overview Table 72. Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Product Portfolio Table 74. Jiangsu Chia Tai Fenghai Pharmaceutical Recent Development Table 75. Grand Pharmaceutical Company Information Table 76. Grand Pharmaceutical Business Overview Table 77. Grand Pharmaceutical Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Grand Pharmaceutical Steroidal MRAs Product Portfolio Table 79. Grand Pharmaceutical Recent Development Table 80. Yatai Pharma Company Information Table 81. Yatai Pharma Business Overview Table 82. Yatai Pharma Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Yatai Pharma Steroidal MRAs Product Portfolio Table 84. Yatai Pharma Recent Development Table 85. Suzhou Homesun Pharmaceutical Company Information Table 86. Suzhou Homesun Pharmaceutical Business Overview Table 87. Suzhou Homesun Pharmaceutical Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Suzhou Homesun Pharmaceutical Steroidal MRAs Product Portfolio Table 89. Suzhou Homesun Pharmaceutical Recent Development Table 90. Shanghai Xinyi Wanxiang pharmaceutical Company Information Table 91. Shanghai Xinyi Wanxiang pharmaceutical Business Overview Table 92. Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Product Portfolio Table 94. Shanghai Xinyi Wanxiang pharmaceutical Recent Development Table 95. Jiangsu Changjiang Pharmaceutical Company Information Table 96. Jiangsu Changjiang Pharmaceutical Business Overview Table 97. Jiangsu Changjiang Pharmaceutical Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Jiangsu Changjiang Pharmaceutical Steroidal MRAs Product Portfolio Table 99. Jiangsu Changjiang Pharmaceutical Recent Development Table 100. Jiangsu Yunyang Pharmaceutical Group Company Information Table 101. Jiangsu Yunyang Pharmaceutical Group Business Overview Table 102. Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Product Portfolio Table 104. Jiangsu Yunyang Pharmaceutical Group Recent Development Table 105. Hangzhou Minsheng Pharmaceutical Company Information Table 106. Hangzhou Minsheng Pharmaceutical Business Overview Table 107. Hangzhou Minsheng Pharmaceutical Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Hangzhou Minsheng Pharmaceutical Steroidal MRAs Product Portfolio Table 109. Hangzhou Minsheng Pharmaceutical Recent Development Table 110. Sinopharm Zhonglian Pharmaceutical Company Information Table 111. Sinopharm Zhonglian Pharmaceutical Business Overview Table 112. Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Product Portfolio Table 114. Sinopharm Zhonglian Pharmaceutical Recent Development Table 115. Zydus Company Information Table 116. Zydus Business Overview Table 117. Zydus Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Zydus Steroidal MRAs Product Portfolio Table 119. Zydus Recent Development Table 120. Viatris Pharmaceuticals Company Information Table 121. Viatris Pharmaceuticals Business Overview Table 122. Viatris Pharmaceuticals Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Viatris Pharmaceuticals Steroidal MRAs Product Portfolio Table 124. Viatris Pharmaceuticals Recent Development Table 125. Sun Pharmaceuticals Company Information Table 126. Sun Pharmaceuticals Business Overview Table 127. Sun Pharmaceuticals Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Sun Pharmaceuticals Steroidal MRAs Product Portfolio Table 129. Sun Pharmaceuticals Recent Development Table 130. Sandoz Company Information Table 131. Sandoz Business Overview Table 132. Sandoz Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Sandoz Steroidal MRAs Product Portfolio Table 134. Sandoz Recent Development Table 135. Pfizer Company Information Table 136. Pfizer Business Overview Table 137. Pfizer Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Pfizer Steroidal MRAs Product Portfolio Table 139. Pfizer Recent Development Table 140. Mylan Company Information Table 141. Mylan Business Overview Table 142. Mylan Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Mylan Steroidal MRAs Product Portfolio Table 144. Mylan Recent Development Table 145. MSN Company Information Table 146. MSN Business Overview Table 147. MSN Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. MSN Steroidal MRAs Product Portfolio Table 149. MSN Recent Development Table 150. Kyorin Rimedio Company Information Table 151. Kyorin Rimedio Business Overview Table 152. Kyorin Rimedio Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Kyorin Rimedio Steroidal MRAs Product Portfolio Table 154. Kyorin Rimedio Recent Development Table 155. Camber Pharmaceuticals Company Information Table 156. Camber Pharmaceuticals Business Overview Table 157. Camber Pharmaceuticals Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Camber Pharmaceuticals Steroidal MRAs Product Portfolio Table 159. Camber Pharmaceuticals Recent Development Table 160. Amneal Pharmaceuticals Company Information Table 161. Amneal Pharmaceuticals Business Overview Table 162. Amneal Pharmaceuticals Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Amneal Pharmaceuticals Steroidal MRAs Product Portfolio Table 164. Amneal Pharmaceuticals Recent Development Table 165. Actavis Elizabeth Company Information Table 166. Actavis Elizabeth Business Overview Table 167. Actavis Elizabeth Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Actavis Elizabeth Steroidal MRAs Product Portfolio Table 169. Actavis Elizabeth Recent Development Table 170. Accord Healthcare Company Information Table 171. Accord Healthcare Business Overview Table 172. Accord Healthcare Steroidal MRAs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Accord Healthcare Steroidal MRAs Product Portfolio Table 174. Accord Healthcare Recent Development Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Steroidal MRAs Distributors List Table 178. Steroidal MRAs Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Steroidal MRAs Product Image Figure 2. Global Steroidal MRAs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Steroidal MRAs Market Size (2021-2032) & (US$ Million) Figure 4. Global Steroidal MRAs Sales (2021-2032) & (K Units) Figure 5. Global Steroidal MRAs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Steroidal MRAs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Spironolactone Image Figure 9. Eplerenone Image Figure 10. Global Steroidal MRAs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Steroidal MRAs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Steroidal MRAs Sales Market Share by Type (2021-2032) Figure 13. Global Steroidal MRAs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Steroidal MRAs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Steroidal MRAs Revenue Market Share by Type (2021-2032) Figure 16. Hypertension Image Figure 17. Aldosteronism Image Figure 18. Edema Image Figure 19. Heart failure Image Figure 20. Others Image Figure 21. Global Steroidal MRAs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Steroidal MRAs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Steroidal MRAs Sales Market Share by Application (2021-2032) Figure 24. Global Steroidal MRAs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Steroidal MRAs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Steroidal MRAs Revenue Market Share by Application (2021-2032) Figure 27. North America Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Steroidal MRAs Sales Market Share by Country (2021-2032) Figure 29. U.S. Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Steroidal MRAs Sales Market Share by Country (2021-2032) Figure 34. Germany Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Steroidal MRAs Sales Market Share by Country (2021-2032) Figure 41. China Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Steroidal MRAs Sales Market Share by Country (2021-2032) Figure 49. Brazil Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Steroidal MRAs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Steroidal MRAs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Steroidal MRAs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Steroidal MRAs Revenue (2021-2032) & (US$ Million) Figure 60. North America Steroidal MRAs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Steroidal MRAs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Steroidal MRAs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Steroidal MRAs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Steroidal MRAs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Steroidal MRAs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Steroidal MRAs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Steroidal MRAs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Steroidal MRAs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Spironolactone
  • Eplerenone
Applications
  • Hypertension
  • Aldosteronism
  • Edema
  • Heart failure
  • Others
Companies covered
  • Chongqing Kerui Pharmaceutical
  • Jiangsu Chia Tai Fenghai Pharmaceutical
  • Grand Pharmaceutical
  • Yatai Pharma
  • Suzhou Homesun Pharmaceutical
  • Shanghai Xinyi Wanxiang pharmaceutical
  • Jiangsu Changjiang Pharmaceutical
  • Jiangsu Yunyang Pharmaceutical Group
  • Hangzhou Minsheng Pharmaceutical
  • Sinopharm Zhonglian Pharmaceutical
  • Zydus
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals
  • Sandoz
  • Pfizer
  • Mylan
  • MSN
  • Kyorin Rimedio
  • Camber Pharmaceuticals
  • Amneal Pharmaceuticals
  • Actavis Elizabeth
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Steroidal MRAs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Steroidal MRAs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Steroidal MRAs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Steroidal MRAs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Steroidal MRAs Market Dynamics
  1. 2.1 Steroidal MRAs Industry Trends
  2. 2.2 Steroidal MRAs Industry Drivers
  3. 2.3 Steroidal MRAs Industry Opportunities and Challenges
  4. 2.4 Steroidal MRAs Industry Restraints
3 Steroidal MRAs Market by Manufacturers
  1. 3.1 Global Steroidal MRAs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Steroidal MRAs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Steroidal MRAs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Steroidal MRAs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Steroidal MRAs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Steroidal MRAs Manufacturers, Product Type & Application
  7. 3.7 Global Steroidal MRAs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Steroidal MRAs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Steroidal MRAs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Steroidal MRAs Tier 1, Tier 2, and Tier 3
4 Steroidal MRAs Market by Type
  1. 4.1 Steroidal MRAs Type Introduction
  2. 4.1.1 Spironolactone
  3. 4.1.2 Eplerenone
  4. 4.2 Global Steroidal MRAs Sales by Type
  5. 4.2.1 Global Steroidal MRAs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Steroidal MRAs Sales by Type (2021-2032)
  7. 4.2.3 Global Steroidal MRAs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Steroidal MRAs Revenue by Type
  9. 4.3.1 Global Steroidal MRAs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Steroidal MRAs Revenue by Type (2021-2032)
  11. 4.3.3 Global Steroidal MRAs Revenue Market Share by Type (2021-2032)
5 Steroidal MRAs Market by Application
  1. 5.1 Steroidal MRAs Application Introduction
  2. 5.1.1 Hypertension
  3. 5.1.2 Aldosteronism
  4. 5.1.3 Edema
  5. 5.1.4 Heart failure
  6. 5.1.5 Others
  7. 5.2 Global Steroidal MRAs Sales by Application
  8. 5.2.1 Global Steroidal MRAs Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Steroidal MRAs Sales by Application (2021-2032)
  10. 5.2.3 Global Steroidal MRAs Sales Market Share by Application (2021-2032)
  11. 5.3 Global Steroidal MRAs Revenue by Application
  12. 5.3.1 Global Steroidal MRAs Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Steroidal MRAs Revenue by Application (2021-2032)
  14. 5.3.3 Global Steroidal MRAs Revenue Market Share by Application (2021-2032)
6 Global Steroidal MRAs Sales by Region
  1. 6.1 Global Steroidal MRAs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Steroidal MRAs Sales by Region (2021-2032)
  3. 6.2.1 Global Steroidal MRAs Sales by Region (2021-2026)
  4. 6.2.2 Global Steroidal MRAs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Steroidal MRAs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Steroidal MRAs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Steroidal MRAs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Steroidal MRAs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Steroidal MRAs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Steroidal MRAs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Steroidal MRAs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Steroidal MRAs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Steroidal MRAs Revenue by Region
  1. 7.1 Global Steroidal MRAs Revenue by Region
  2. 7.1.1 Global Steroidal MRAs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Steroidal MRAs Revenue by Region (2021-2026)
  4. 7.1.3 Global Steroidal MRAs Revenue by Region (2027-2032)
  5. 7.1.4 Global Steroidal MRAs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Steroidal MRAs Revenue (2021-2032)
  8. 7.2.2 North America Steroidal MRAs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Steroidal MRAs Revenue (2021-2032)
  11. 7.3.2 Europe Steroidal MRAs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Steroidal MRAs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Steroidal MRAs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Steroidal MRAs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Steroidal MRAs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Kerui Pharmaceutical
  2. 8.1.1 Chongqing Kerui Pharmaceutical Company Information
  3. 8.1.2 Chongqing Kerui Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Kerui Pharmaceutical Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Kerui Pharmaceutical Steroidal MRAs Product Portfolio
  6. 8.1.5 Chongqing Kerui Pharmaceutical Recent Developments
  7. 8.2 Jiangsu Chia Tai Fenghai Pharmaceutical
  8. 8.2.1 Jiangsu Chia Tai Fenghai Pharmaceutical Company Information
  9. 8.2.2 Jiangsu Chia Tai Fenghai Pharmaceutical Business Overview
  10. 8.2.3 Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Product Portfolio
  12. 8.2.5 Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments
  13. 8.3 Grand Pharmaceutical
  14. 8.3.1 Grand Pharmaceutical Company Information
  15. 8.3.2 Grand Pharmaceutical Business Overview
  16. 8.3.3 Grand Pharmaceutical Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grand Pharmaceutical Steroidal MRAs Product Portfolio
  18. 8.3.5 Grand Pharmaceutical Recent Developments
  19. 8.4 Yatai Pharma
  20. 8.4.1 Yatai Pharma Company Information
  21. 8.4.2 Yatai Pharma Business Overview
  22. 8.4.3 Yatai Pharma Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Yatai Pharma Steroidal MRAs Product Portfolio
  24. 8.4.5 Yatai Pharma Recent Developments
  25. 8.5 Suzhou Homesun Pharmaceutical
  26. 8.5.1 Suzhou Homesun Pharmaceutical Company Information
  27. 8.5.2 Suzhou Homesun Pharmaceutical Business Overview
  28. 8.5.3 Suzhou Homesun Pharmaceutical Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Suzhou Homesun Pharmaceutical Steroidal MRAs Product Portfolio
  30. 8.5.5 Suzhou Homesun Pharmaceutical Recent Developments
  31. 8.6 Shanghai Xinyi Wanxiang pharmaceutical
  32. 8.6.1 Shanghai Xinyi Wanxiang pharmaceutical Company Information
  33. 8.6.2 Shanghai Xinyi Wanxiang pharmaceutical Business Overview
  34. 8.6.3 Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Product Portfolio
  36. 8.6.5 Shanghai Xinyi Wanxiang pharmaceutical Recent Developments
  37. 8.7 Jiangsu Changjiang Pharmaceutical
  38. 8.7.1 Jiangsu Changjiang Pharmaceutical Company Information
  39. 8.7.2 Jiangsu Changjiang Pharmaceutical Business Overview
  40. 8.7.3 Jiangsu Changjiang Pharmaceutical Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Changjiang Pharmaceutical Steroidal MRAs Product Portfolio
  42. 8.7.5 Jiangsu Changjiang Pharmaceutical Recent Developments
  43. 8.8 Jiangsu Yunyang Pharmaceutical Group
  44. 8.8.1 Jiangsu Yunyang Pharmaceutical Group Company Information
  45. 8.8.2 Jiangsu Yunyang Pharmaceutical Group Business Overview
  46. 8.8.3 Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Product Portfolio
  48. 8.8.5 Jiangsu Yunyang Pharmaceutical Group Recent Developments
  49. 8.9 Hangzhou Minsheng Pharmaceutical
  50. 8.9.1 Hangzhou Minsheng Pharmaceutical Company Information
  51. 8.9.2 Hangzhou Minsheng Pharmaceutical Business Overview
  52. 8.9.3 Hangzhou Minsheng Pharmaceutical Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hangzhou Minsheng Pharmaceutical Steroidal MRAs Product Portfolio
  54. 8.9.5 Hangzhou Minsheng Pharmaceutical Recent Developments
  55. 8.10 Sinopharm Zhonglian Pharmaceutical
  56. 8.10.1 Sinopharm Zhonglian Pharmaceutical Company Information
  57. 8.10.2 Sinopharm Zhonglian Pharmaceutical Business Overview
  58. 8.10.3 Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Product Portfolio
  60. 8.10.5 Sinopharm Zhonglian Pharmaceutical Recent Developments
  61. 8.11 Zydus
  62. 8.11.1 Zydus Company Information
  63. 8.11.2 Zydus Business Overview
  64. 8.11.3 Zydus Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zydus Steroidal MRAs Product Portfolio
  66. 8.11.5 Zydus Recent Developments
  67. 8.12 Viatris Pharmaceuticals
  68. 8.12.1 Viatris Pharmaceuticals Company Information
  69. 8.12.2 Viatris Pharmaceuticals Business Overview
  70. 8.12.3 Viatris Pharmaceuticals Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Viatris Pharmaceuticals Steroidal MRAs Product Portfolio
  72. 8.12.5 Viatris Pharmaceuticals Recent Developments
  73. 8.13 Sun Pharmaceuticals
  74. 8.13.1 Sun Pharmaceuticals Company Information
  75. 8.13.2 Sun Pharmaceuticals Business Overview
  76. 8.13.3 Sun Pharmaceuticals Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sun Pharmaceuticals Steroidal MRAs Product Portfolio
  78. 8.13.5 Sun Pharmaceuticals Recent Developments
  79. 8.14 Sandoz
  80. 8.14.1 Sandoz Company Information
  81. 8.14.2 Sandoz Business Overview
  82. 8.14.3 Sandoz Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sandoz Steroidal MRAs Product Portfolio
  84. 8.14.5 Sandoz Recent Developments
  85. 8.15 Pfizer
  86. 8.15.1 Pfizer Company Information
  87. 8.15.2 Pfizer Business Overview
  88. 8.15.3 Pfizer Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Pfizer Steroidal MRAs Product Portfolio
  90. 8.15.5 Pfizer Recent Developments
  91. 8.16 Mylan
  92. 8.16.1 Mylan Company Information
  93. 8.16.2 Mylan Business Overview
  94. 8.16.3 Mylan Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Mylan Steroidal MRAs Product Portfolio
  96. 8.16.5 Mylan Recent Developments
  97. 8.17 MSN
  98. 8.17.1 MSN Company Information
  99. 8.17.2 MSN Business Overview
  100. 8.17.3 MSN Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 MSN Steroidal MRAs Product Portfolio
  102. 8.17.5 MSN Recent Developments
  103. 8.18 Kyorin Rimedio
  104. 8.18.1 Kyorin Rimedio Company Information
  105. 8.18.2 Kyorin Rimedio Business Overview
  106. 8.18.3 Kyorin Rimedio Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Kyorin Rimedio Steroidal MRAs Product Portfolio
  108. 8.18.5 Kyorin Rimedio Recent Developments
  109. 8.19 Camber Pharmaceuticals
  110. 8.19.1 Camber Pharmaceuticals Company Information
  111. 8.19.2 Camber Pharmaceuticals Business Overview
  112. 8.19.3 Camber Pharmaceuticals Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Camber Pharmaceuticals Steroidal MRAs Product Portfolio
  114. 8.19.5 Camber Pharmaceuticals Recent Developments
  115. 8.20 Amneal Pharmaceuticals
  116. 8.20.1 Amneal Pharmaceuticals Company Information
  117. 8.20.2 Amneal Pharmaceuticals Business Overview
  118. 8.20.3 Amneal Pharmaceuticals Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Amneal Pharmaceuticals Steroidal MRAs Product Portfolio
  120. 8.20.5 Amneal Pharmaceuticals Recent Developments
  121. 8.21 Actavis Elizabeth
  122. 8.21.1 Actavis Elizabeth Company Information
  123. 8.21.2 Actavis Elizabeth Business Overview
  124. 8.21.3 Actavis Elizabeth Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Actavis Elizabeth Steroidal MRAs Product Portfolio
  126. 8.21.5 Actavis Elizabeth Recent Developments
  127. 8.22 Accord Healthcare
  128. 8.22.1 Accord Healthcare Company Information
  129. 8.22.2 Accord Healthcare Business Overview
  130. 8.22.3 Accord Healthcare Steroidal MRAs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Accord Healthcare Steroidal MRAs Product Portfolio
  132. 8.22.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Steroidal MRAs Value Chain Analysis
  2. 9.1.1 Steroidal MRAs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Steroidal MRAs Production Mode & Process
  6. 9.2 Steroidal MRAs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Steroidal MRAs Distributors
  9. 9.2.3 Steroidal MRAs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst